These data indicated that RAD18 may regulate radioresistance by facilitating NHEJ via phosphorylation of DNA‐PKcs in ESCC cells, providing a novel radiotherapy target for ESCC. This evidence concerns the gene PRKDC and esophageal squamous cell carcinoma.